For the quarter ending 2026-03-31, MFA-PB had $24,143K increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income/(loss) | -984 | 54,319 | 122,464 |
| Net (gain)/loss on residential whole loans | -32,092 | 5,807 | 133,033 |
| Impairment and other net (gain)/loss on securities and other portfolio investments, net | 38,271 | -15,715 | -45,828 |
| Net (gain)/loss on real estate owned | -3,029 | -2,677 | -4,210 |
| Accretion of purchase discounts and amortization of purchase premiums on residential whole loans and securities | -3,151 | -1,910 | 682 |
| Provision/(reversal of provision) for credit losses on residential whole loans and other assets | -241 | -276 | 1,212 |
| Net (gain)/loss on derivatives used for risk management purposes | 26,767 | 602 | -66,214 |
| Net (gain)/loss on securitized debt measured at fair value through earnings | 22,901 | 1,586 | -43,589 |
| Net margin received/(paid) for derivatives used for risk management purposes | -13,485 | -108 | 96,176 |
| Net other non-cash (gains)/losses included in net income | 7,253 | 7,711 | 59,688 |
| (increase)/decrease in other assets | -23,612 | 4,699 | -9,164 |
| Increase/(decrease) in other liabilities | 1,070 | -414 | 7,797 |
| Net cash provided by/(used in) operating activities | 71,070 | 37,626 | 38,619 |
| Purchases and origination of residential whole loans, loan related investments and capitalized advances | 675,729 | 658,331 | 2,030,362 |
| Proceeds from sales of residential whole loans | 85,791 | 54,628 | 220,293 |
| Principal payments on residential whole loans and loan related investments | 551,547 | 591,146 | 1,845,793 |
| Purchases of securities | 350,944 | 1,345,070 | 817,636 |
| Proceeds from sales of securities and other assets | 1,561 | 26,023 | 20,790 |
| Principal payments on securities | 128,077 | 117,731 | 171,918 |
| Proceeds from sales of real estate owned | 26,287 | 22,472 | 73,957 |
| Other investing activities | -7,796 | 40,074 | 38,779 |
| Net cash provided by/(used in) investing activities | -225,614 | -1,231,475 | -554,026 |
| Principal payments on financing agreements with mark-to-market collateral provisions | 797,391 | 680,790 | 2,014,431 |
| Proceeds from borrowings under financing agreements with mark-to-market collateral provisions | 1,057,410 | 1,865,247 | 2,477,850 |
| Principal payments on other collateralized financing agreements | 813,830 | 608,191 | 1,293,259 |
| Proceeds from borrowings under other collateralized financing agreements | 797,120 | 519,624 | 1,461,303 |
| Payments made for other collateralized financing agreement related costs | 2,953 | 2,853 | 8,039 |
| Redemption and repurchase of convertible senior notes | - | 0 | 0 |
| Proceeds from issuance of senior notes | - | 0 | 0 |
| Payments made for settlements and unwinds of swaps | 6,759 | 1,258 | 26,020 |
| Proceeds from issuance of preferred stock, net of expenses | 3,427 | 4,779 | 4,532 |
| Payments made for costs related to preferred stock issuance | - | - | 74 |
| Proceeds from issuances of common stock, net of expenses | -10 | -7 | -61 |
| Payments made for the repurchase of common stock | 9,033 | 5,047 | 10,266 |
| Dividends paid on preferred stock | 10,424 | 10,704 | 29,613 |
| Dividends paid on common stock and dividend equivalents | 38,870 | 37,326 | 110,858 |
| Net cash provided by/(used in) financing activities | 178,687 | 1,043,548 | 451,064 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash | 24,143 | -150,301 | -64,343 |
| Cash, cash equivalents and restricted cash at beginning of period | 386,668 | 536,969 | 601,312 |
| Cash, cash equivalents and restricted cash at end of period | 410,811 | 386,668 | 536,969 |
MFA FINANCIAL, INC. (MFA-PB)
MFA FINANCIAL, INC. (MFA-PB)